Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Response from PTSC IR regarding issuance of preferred stock..

"In any event, the Company has no plans at this time, or in the foreseeable future, that would call for the issuance of preferred stock, but it retains the ability and flexibility to do so if warranted

Cliff Flowers (CFO) has asked if you would like to speak with him directly on this subject to provide your phone number and he will give you a call.

Best regards,

Angela Hartley Investor Relations"

Sorry folks, not sure why I can't get the entire message to fit. I definitely like Angela more than the old IR firm. Anyways, good luck to you, me, us, and all longs.

Share
New Message
Please login to post a reply